Published in Mol Imaging Biol on November 25, 2008
Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET. J Nucl Med (2011) 1.07
Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer. Curr Opin Oncol (2009) 0.98
Targeting prostate cancer cells in vivo using a rapidly internalizing novel human single-chain antibody fragment. J Nucl Med (2010) 0.89
Functional imaging for prostate cancer: therapeutic implications. Semin Nucl Med (2012) 0.85
Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry. Mol Pharm (2013) 0.84
Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles. J Control Release (2015) 0.80
A hardware investigation of robotic SPECT for functional and molecular imaging onboard radiation therapy systems. Med Phys (2014) 0.75
Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model. EJNMMI Res (2017) 0.75
Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides. J Nucl Med (1995) 3.50
Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer. J Clin Oncol (2005) 3.01
Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology (1996) 2.77
Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer (1993) 2.31
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancer. J Clin Oncol (2004) 2.27
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res (1988) 1.91
In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. Cancer Res (2000) 1.91
Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. J Urol (2003) 1.57
Prostate-specific membrane antigen regulates angiogenesis by modulating integrin signal transduction. Mol Cell Biol (2006) 1.48
Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer (1995) 1.43
Prostate-specific membrane antigen. Prostate (1997) 1.25
Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line. Prostate (1997) 1.25
Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies. Cancer Immunol Immunother (2004) 1.08
Current status of lymph node-positive prostate cancer: Incidence and predictors of outcome. Cancer (2006) 1.05
Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system. J Nucl Med (2005) 1.01
N-glycosylation and microtubule integrity are involved in apical targeting of prostate-specific membrane antigen: implications for immunotherapy. Mol Cancer Ther (2005) 0.94
Monoclonal antibody 7E11.C5 staining of viable LNCaP cells. Prostate (1997) 0.91
ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients. Prostate (1998) 0.87
Treatment options in lymph node-positive prostate cancer. Cancer (2006) 0.87
Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer. Prostate Cancer Prostatic Dis (2000) 0.86
Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76
Prevalence of diabetes among men and women in China. N Engl J Med (2010) 19.98
Prevalence and control of diabetes in Chinese adults. JAMA (2013) 11.73
Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med (2005) 8.95
Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA (2002) 7.93
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89
Worldwide prevalence of hypertension: a systematic review. J Hypertens (2004) 6.25
Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med (2002) 5.92
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86
The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med (2004) 5.45
Effects of low-carbohydrate and low-fat diets: a randomized trial. Ann Intern Med (2014) 5.31
Prevalence of the metabolic syndrome and overweight among adults in China. Lancet (2005) 5.05
APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00
Mortality attributable to smoking in China. N Engl J Med (2009) 4.75
Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med (2006) 4.69
Fast, three-dimensional super-resolution imaging of live cells. Nat Methods (2011) 4.52
Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med (2009) 4.19
Prevalence, awareness, treatment, and control of hypertension in china. Hypertension (2002) 4.18
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16
Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA (2011) 4.09
Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet (2011) 4.04
Trends in blood pressure among children and adolescents. JAMA (2004) 4.03
Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr (2002) 4.00
Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol (2002) 3.92
The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab (2012) 3.81
Alcohol consumption and risk of stroke: a meta-analysis. JAMA (2003) 3.54
Body weight and mortality among men and women in China. JAMA (2006) 3.41
Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA (2006) 3.39
Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol (2004) 3.00
Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension (2007) 2.98
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med (2004) 2.94
Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study. Lancet (2009) 2.73
Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70
X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med (2003) 2.65
Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes (2010) 2.63
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrol Dial Transplant (2011) 2.60
Selective activation of p53-mediated tumour suppression in high-grade tumours. Nature (2010) 2.51
Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int (2013) 2.48
Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med (2004) 2.42
Body mass index and risk of stroke among Chinese men and women. Ann Neurol (2010) 2.33
Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med (2003) 2.22
Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation (2005) 2.13
Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol (2012) 2.10
Measured GFR does not outperform estimated GFR in predicting CKD-related complications. J Am Soc Nephrol (2011) 2.06
Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat Genet (2012) 2.05
Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. Am J Public Health (2004) 2.02
Prevalence and risk factors of overweight and obesity in China. Obesity (Silver Spring) (2007) 1.93
Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium. Am J Epidemiol (2015) 1.87
Health care expenditure prediction with a single item, self-rated health measure. Med Care (2009) 1.87
Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol (2007) 1.84
Prehypertension and risk of cardiovascular disease in Chinese adults. J Hypertens (2009) 1.81
The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc Natl Acad Sci U S A (2007) 1.79
Alcohol consumption and risk for stroke among Chinese men. Ann Neurol (2007) 1.79
Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol (2013) 1.78
Genetic epidemiology of obesity. Epidemiol Rev (2007) 1.78
Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr (2004) 1.77
Blood lead level is associated with elevated blood pressure in blacks. Hypertension (2003) 1.75
Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant (2012) 1.75
Blood pressure and risk of cardiovascular disease in Chinese men and women. Am J Hypertens (2008) 1.74
Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol (2003) 1.70
Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Stroke (2002) 1.69
Association of cardiac troponin T with left ventricular structure and function in CKD. Am J Kidney Dis (2013) 1.67
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. Pediatr Blood Cancer (2006) 1.66
Genomic epidemiology of blood pressure salt sensitivity. J Hypertens (2012) 1.65
Measures of adiposity and cardiovascular disease risk factors. Obesity (Silver Spring) (2007) 1.64
Prevalence of physical activity among Chinese adults: results from the International Collaborative Study of Cardiovascular Disease in Asia. Am J Public Health (2005) 1.63
Reproducibility of blood pressure responses to dietary sodium and potassium interventions: the GenSalt study. Hypertension (2013) 1.59
Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population. J Mol Med (Berl) (2007) 1.58
Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. Diabetes Res Clin Pract (2008) 1.57
Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China. Circ Cardiovasc Qual Outcomes (2014) 1.56
Pretargeting in tumored mice with radiolabeled morpholino oligomer showing low kidney uptake. Eur J Nucl Med Mol Imaging (2003) 1.56
Body mass index and diabetes in Asia: a cross-sectional pooled analysis of 900,000 individuals in the Asia cohort consortium. PLoS One (2011) 1.55
Association between blood pressure responses to the cold pressor test and dietary sodium intervention in a Chinese population. Arch Intern Med (2008) 1.53
Radiation dose estimate in small animal SPECT and PET. Med Phys (2004) 1.52
Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting. Appl Radiat Isot (2006) 1.52
Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med (2007) 1.49
A multipinhole small animal SPECT system with submillimeter spatial resolution. Med Phys (2006) 1.49
Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor. Eur J Nucl Med Mol Imaging (2005) 1.48
Blood pressure response to potassium supplementation is associated with genetic variation in endothelin 1 and interactions with E selectin in rural Chinese. J Hypertens (2010) 1.47
Trends in overweight and obesity in Chinese adults: between 1991 and 1999-2000. Obesity (Silver Spring) (2008) 1.46
Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. Hypertension (2008) 1.46
Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens (2003) 1.45
Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int (2003) 1.45
Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med (2003) 1.43
A novel approach to multipinhole SPECT for myocardial perfusion imaging. J Nucl Med (2006) 1.43
Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int (2005) 1.42
Urine angiotensinogen and salt-sensitivity and potassium-sensitivity of blood pressure. J Hypertens (2015) 1.42
Association between inflammation and insulin resistance in U.S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey. Diabetes Care (2004) 1.40
Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens (2005) 1.40
Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol (2012) 1.40
Intravenous vasopressin for the prevention of nontarget gastrointestinal embolization during liver-directed cancer treatment: experimental study in a porcine model. J Vasc Interv Radiol (2012) 1.37
Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol (2006) 1.36
Small-animal SPECT and SPECT/CT: important tools for preclinical investigation. J Nucl Med (2008) 1.35
Intracellular cargo delivery by an octaarginine transporter adapted to target prostate cancer cells through cell surface protease activation. Bioconjug Chem (2006) 1.35
Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma. Cancer Res (2009) 1.34